These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7797157)

  • 21. [Treatment of hypercholesteremia in the prevention of coronary disease: is the controversy finally settled?].
    Nikkilä E
    Duodecim; 1984; 100(20):1289-93. PubMed ID: 6510291
    [No Abstract]   [Full Text] [Related]  

  • 22. American Academy of Pediatrics. Committee on Nutrition. Cholesterol in childhood.
    American Academy of Pediatrics. Committee on Nutrition
    Pediatrics; 1998 Jan; 101(1 Pt 1):141-7. PubMed ID: 11345978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cholesterol levels in young men and women planning conception].
    Czeizel E; Kollega-Tarsoly E; Kalina A; Pál M; Pados G
    Orv Hetil; 1996 Jan; 137(3):125-8. PubMed ID: 8721863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guidelines for detection and management of dyslipidaemia. Scientific Committee of the National Heart Foundation of New Zealand.
    Mann JI; Crooke M; Fear H; Hay DR; Jackson RT; Neutze JM; White HD
    N Z Med J; 1993 Apr; 106(953):133-41. PubMed ID: 8474734
    [No Abstract]   [Full Text] [Related]  

  • 25. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of hypercholesterolemia in secondary prevention. Statement of the Italian National Association of Hospital Cardiologists].
    Marchioli R; Valagussa F; Vanuzzo D; Giannuzzi P; Pede S; Schweiger C
    G Ital Cardiol; 1998 Apr; 28(4):409-15. PubMed ID: 9616858
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evidence of the efficacy of hypocholesterolemic treatment in primary and secondary prevention of ischemic heart disease].
    Alvarez-Sala Walther LA; Millán Núñez-Cortés J
    Med Clin (Barc); 2000; 114 Suppl 2():1-10. PubMed ID: 10916798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary prevention of CHD: nine ways to reduce risk.
    Havranek EP
    Am Fam Physician; 1999 Mar; 59(6):1455-63, 1466. PubMed ID: 10193589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperlipidaemia and the prevention of coronary heart disease.
    Scott RS; Lintott CJ; Bremer J; Nye ER
    N Z Med J; 1987 Nov; 100(836):717-9. PubMed ID: 3452167
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Strategy for the prevention of ischemic heart disease. Directives from the European Society of Atherosclerosis].
    Assmann G; Lewis B; Mancini M; Paoletti R; Schettler G
    Rev Esp Cardiol; 1987; 40(1):8-9. PubMed ID: 3823588
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyörälä K; De Backer G; Graham I; Poole-Wilson P; Wood D; Force T
    Cardiologia; 1996 Feb; 41(2):149-82. PubMed ID: 8674094
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on managing hypercholesterolemia. The new NCEP guidelines.
    Kuhar MB
    AAOHN J; 2002 Aug; 50(8):360-4. PubMed ID: 12227210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How concerned are elderly patients without coronary heart disease about hypercholesterolemia and heart disease? An UPRNet study. Upper Peninsula Research Network.
    Reddy E; Kreher N; Hickner JM
    J Fam Pract; 1998 Mar; 46(3):227-32. PubMed ID: 9519020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)].
    de Backer G; Graham I; Poole-Wilson P; Pyörälä K; Shepherd J; Wood D; Zanchetti A
    Rev Esp Cardiol; 1995 Dec; 48(12):773-80. PubMed ID: 8685497
    [No Abstract]   [Full Text] [Related]  

  • 36. [Methods of mass early detection and prevention of atherosclerosis (especially ischemic cardiopathy)].
    Steinbach M; Popescu I; Constantineanu M; Harnagea P; Teodorini S
    Stud Cercet Med Interna; 1970; 11(4):323-43. PubMed ID: 5474705
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevention of coronary disease: general policy of the European Atherosclerosis Society].
    Jacotot B; Ghembaza T
    Rev Prat; 1988 Jun; 38(19):1276-80. PubMed ID: 3175497
    [No Abstract]   [Full Text] [Related]  

  • 38. The pharmacoeconomic benefits of cholesterol reduction.
    Gonzalez ER
    Am J Manag Care; 1998 Feb; 4(2):223-30. PubMed ID: 10178493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The heart of the matter. National guidelines urge more aggressive cholesterol treatment.
    Leake NB
    Adv Nurse Pract; 2002 Jan; 10(1):42-7; quiz 48-9. PubMed ID: 12420511
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevent coronary heart disease. A summary from a joint report of the European Society of Atherosclerosis with Norwegian comments].
    Bjartveit K; Norum K; Thelle DS
    Tidsskr Nor Laegeforen; 1987 May; 107(14):1238-40. PubMed ID: 3603489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.